首页 > 最新文献

Clinical Neuropsychiatry最新文献

英文 中文
Exploring Transference in Borderline Personality Disorder: An Empirical Study of Facial Resemblance and Emotional Valence. 探索边缘型人格障碍的移情作用:面部相似性与情感价值的实证研究》。
IF 6.1 Q3 CLINICAL NEUROLOGY Pub Date : 2024-04-01 DOI: 10.36131/cnfioritieditore20240202
Abdulhadi Kocabas, Georg Juckel, Nikolai Axmacher, Gerd Waldhauser, Martin Brüne

Objective: Transference is a psychological process where feelings and attitudes towards a familiar person are unconsciously redirected to another. This phenomenon can be activated by physical resemblance, including facial features. Despite its potential therapeutic significance, little research has investigated transference processes in individuals with psychiatric conditions. Here, we explored how patients with borderline personality disorder (BPD)-characterized, among other features, by unstable relationships, self-damaging impulsivity, and suicidal ideation-would exhibit transference of negative and positive attributes.

Method: We performed an experiment where BPD participants and a control group with no prior psychiatric history completed a face-rating task. The task involved an evaluation of images of strangers who resembled significant others in terms of facial features.

Results: Our results indicated that transference effects were elicited in both groups. Notably, there were significant differences in ratings assigned to significant others, whereby participants with BPD displayed transference of negative attributes more and positive attributes less intensely than healthy controls, which, in part, correlated with attachment anxiety.

Conclusions: Our findings align with the tendency in BPD to perceive interpersonal relationships and emotions more negatively. They have potential implications for psychotherapeutic approaches in treating patients with BPD and our understanding of underlying pathophysiological mechanisms of BPD itself.

目的:移情是一种心理过程,即对熟悉的人的情感和态度会不自觉地转移到另一个人身上。包括面部特征在内的身体相似性可以激活这种现象。尽管这种现象具有潜在的治疗意义,但很少有研究对精神病患者的移情过程进行调查。在此,我们探讨了边缘型人格障碍(BPD)患者--除其他特征外,还具有人际关系不稳定、自我伤害冲动和自杀倾向--如何表现出消极和积极属性的移情:我们进行了一项实验,让 BPD 参与者和无精神病史的对照组完成一项面部评分任务。该任务包括对与重要他人面部特征相似的陌生人形象进行评价:结果:我们的研究结果表明,两组受试者都产生了移情效应。值得注意的是,与健康对照组相比,BPD 参与者对重要他人的评价存在显著差异,他们对消极属性的转移程度更高,而对积极属性的转移程度更低,这在一定程度上与依恋焦虑有关:我们的研究结果与 BPD 患者对人际关系和情感的负面认知倾向一致。结论:我们的研究结果与 BPD 患者对人际关系和情感的负面感知倾向一致,这对治疗 BPD 患者的心理治疗方法以及我们对 BPD 本身潜在病理生理机制的理解具有潜在的意义。
{"title":"Exploring Transference in Borderline Personality Disorder: An Empirical Study of Facial Resemblance and Emotional Valence.","authors":"Abdulhadi Kocabas, Georg Juckel, Nikolai Axmacher, Gerd Waldhauser, Martin Brüne","doi":"10.36131/cnfioritieditore20240202","DOIUrl":"10.36131/cnfioritieditore20240202","url":null,"abstract":"<p><strong>Objective: </strong>Transference is a psychological process where feelings and attitudes towards a familiar person are unconsciously redirected to another. This phenomenon can be activated by physical resemblance, including facial features. Despite its potential therapeutic significance, little research has investigated transference processes in individuals with psychiatric conditions. Here, we explored how patients with borderline personality disorder (BPD)-characterized, among other features, by unstable relationships, self-damaging impulsivity, and suicidal ideation-would exhibit transference of negative and positive attributes.</p><p><strong>Method: </strong>We performed an experiment where BPD participants and a control group with no prior psychiatric history completed a face-rating task. The task involved an evaluation of images of strangers who resembled significant others in terms of facial features.</p><p><strong>Results: </strong>Our results indicated that transference effects were elicited in both groups. Notably, there were significant differences in ratings assigned to significant others, whereby participants with BPD displayed transference of negative attributes more and positive attributes less intensely than healthy controls, which, in part, correlated with attachment anxiety.</p><p><strong>Conclusions: </strong>Our findings align with the tendency in BPD to perceive interpersonal relationships and emotions more negatively. They have potential implications for psychotherapeutic approaches in treating patients with BPD and our understanding of underlying pathophysiological mechanisms of BPD itself.</p>","PeriodicalId":46700,"journal":{"name":"Clinical Neuropsychiatry","volume":"21 2","pages":"135-142"},"PeriodicalIF":6.1,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11129342/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141162813","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Main Biological Models of Resilience. 复原力的主要生物学模型。
IF 6.1 Q3 CLINICAL NEUROLOGY Pub Date : 2024-04-01 DOI: 10.36131/cnfioritieditore20240201
Donatella Marazziti, Sara Fantasia, Stefania Palermo, Alessandro Arone, Lucia Massa, Matteo Gambini, Claudia Carmassi

Objective: Resilience is a complex process of adaptation to new conditions that would permit a positive outcome after adversities, traumas or other sources of stress. However, despite the growing interest in this topic, there is no universally accepted definition and no comprehensive bio-behavioural model. This systematic review aims to provide an overview of the main biological models that have been theorized to date, with a focus on new alternative theories to improve our understanding of the mechanisms underlying the development and strengthening of resilience, with potential implications for the prevention of some psychopathological disorders.

Method: This review was conducted according to PRISMA guidelines and includes 185 studies published in English in PubMed and Embase up to December 2023.

Results: Most studies use the stress-related model, which conceptualizes resilience as the absence of symptoms after the stressful event and mainly deal with the differences between stress-prone and resilient phenotypes in animals exposed to stress. However, the results of this search seem to suggest that resilience might be an independent construct with biological bases rooted in the stress system and the social brain, and widely sculptured by individual and environmental factors, especially early life events and affiliation.

Conclusions: This work contributes to ongoing efforts to understand the intricate mechanisms of resilience, while highlighting the potential of improving social relationships since our birth to promote coping strategies towards stress and traumas, and even a peaceful world.

目的:复原力是一个适应新环境的复杂过程,在经历逆境、创伤或其他压力来源后,复原力会带来积极的结果。然而,尽管人们对这一主题的兴趣与日俱增,却没有一个普遍接受的定义,也没有一个全面的生物-行为模型。本系统综述旨在概述迄今为止理论上的主要生物模型,重点关注新的替代理论,以加深我们对抗逆力发展和增强机制的理解,从而对预防某些精神病理障碍产生潜在影响:本综述根据PRISMA指南进行,收录了截至2023年12月在PubMed和Embase上发表的185篇英文研究:大多数研究采用了应激相关模型,该模型将恢复力概念化为应激事件发生后不出现症状,主要研究暴露于应激中的动物的应激易感表型与恢复力表型之间的差异。然而,这项研究的结果似乎表明,抗逆力可能是一个独立的概念,其生物学基础植根于应激系统和社会大脑,并受到个体和环境因素的广泛影响,尤其是早期生活事件和从属关系:这项研究有助于人们了解抗逆力的复杂机制,同时也强调了改善出生后的社会关系,促进对压力和创伤的应对策略,甚至建立一个和平世界的潜力。
{"title":"Main Biological Models of Resilience.","authors":"Donatella Marazziti, Sara Fantasia, Stefania Palermo, Alessandro Arone, Lucia Massa, Matteo Gambini, Claudia Carmassi","doi":"10.36131/cnfioritieditore20240201","DOIUrl":"10.36131/cnfioritieditore20240201","url":null,"abstract":"<p><strong>Objective: </strong>Resilience is a complex process of adaptation to new conditions that would permit a positive outcome after adversities, traumas or other sources of stress. However, despite the growing interest in this topic, there is no universally accepted definition and no comprehensive bio-behavioural model. This systematic review aims to provide an overview of the main biological models that have been theorized to date, with a focus on new alternative theories to improve our understanding of the mechanisms underlying the development and strengthening of resilience, with potential implications for the prevention of some psychopathological disorders.</p><p><strong>Method: </strong>This review was conducted according to PRISMA guidelines and includes 185 studies published in English in PubMed and Embase up to December 2023.</p><p><strong>Results: </strong>Most studies use the stress-related model, which conceptualizes resilience as the absence of symptoms after the stressful event and mainly deal with the differences between stress-prone and resilient phenotypes in animals exposed to stress. However, the results of this search seem to suggest that resilience might be an independent construct with biological bases rooted in the stress system and the social brain, and widely sculptured by individual and environmental factors, especially early life events and affiliation.</p><p><strong>Conclusions: </strong>This work contributes to ongoing efforts to understand the intricate mechanisms of resilience, while highlighting the potential of improving social relationships since our birth to promote coping strategies towards stress and traumas, and even a peaceful world.</p>","PeriodicalId":46700,"journal":{"name":"Clinical Neuropsychiatry","volume":"21 2","pages":"115-134"},"PeriodicalIF":6.1,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11129343/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141162818","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Article Highlights. 文章亮点。
IF 6.1 Q3 CLINICAL NEUROLOGY Pub Date : 2024-04-01
Federico Mucci
{"title":"Article Highlights.","authors":"Federico Mucci","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":46700,"journal":{"name":"Clinical Neuropsychiatry","volume":"21 2","pages":"113-114"},"PeriodicalIF":6.1,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11129339/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141162777","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An Italian Consensus Conference on Psychological Therapies for Anxiety and Depression. 意大利焦虑和抑郁心理疗法共识会议。
IF 6.1 Q3 CLINICAL NEUROLOGY Pub Date : 2024-04-01 DOI: 10.36131/cnfioritieditore20240204
Gioia Bottesi, Gemma Calamandrei, Silvio Garattini, Paolo Migone, Ezio Sanavio
{"title":"An Italian Consensus Conference on Psychological Therapies for Anxiety and Depression.","authors":"Gioia Bottesi, Gemma Calamandrei, Silvio Garattini, Paolo Migone, Ezio Sanavio","doi":"10.36131/cnfioritieditore20240204","DOIUrl":"10.36131/cnfioritieditore20240204","url":null,"abstract":"","PeriodicalId":46700,"journal":{"name":"Clinical Neuropsychiatry","volume":"21 2","pages":"153-154"},"PeriodicalIF":6.1,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11129340/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141162760","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Link Between Problematic Instagram Use and Body-Image Investment Dimensions: The Mediating Role of Social Comparison on Instagram and the Need to Conceal Body Flaws. 有问题的 Instagram 使用与身体形象投资维度之间的联系:Instagram上的社会比较与掩盖身体缺陷的需要的中介作用。
IF 6.1 Q3 CLINICAL NEUROLOGY Pub Date : 2024-02-01 DOI: 10.36131/cnfioritieditore20240105
Silvia Casale, Chiara Pettini, Giulia Fioravanti, Massimiliano Padovani, Simon Ghinassi

Objective: The negative effects of Problematic Instagram Use (PIU) on self-evaluations of one's appearance (i.e., body-image satisfaction-dissatisfaction) are well-known, whereas less explored is its role on body-image investment dimensions. By adopting the Social Comparison and the Self-discrepancies theories as the framework, the present study hypothesized that PIU negatively affects body investment and appearance management behaviours through the serial mediating role of actual appearance comparison on Instagram (IG) and the need to conceal body flaws. Gender, age and trait appearance comparison were controlled for.

Method: A convenience sample of 323 participants (F = 70.3%; M= 28.92 + 10.96) was recruited, and well-known self-report measures were administered online.

Results: The structural model produced good fit indices [χ2/df = 2.36, RMSEA = 0.065 (0.053 - 0.077), CFI = 0.962, SRMR = 0.038], and the variables accounted for 79% and 32% of the variance in body investment and appearance management behaviours, respectively. PIU was associated with body investment both directly and indirectly, whereas it affected appearance management behaviours only via appearance comparison on Ig. The tested alternative model has a poorer fit than the hypothesized model, and the former fitted significantly worse than the proposed one.

Conclusions: The present study represents a step toward a better understanding of the psychological mechanisms underlying the link between PIU and body image investment dimensions.

目的:有问题的 Instagram 使用(PIU)对个人外貌自我评价(即身体形象满意度-不满意度)的负面影响众所周知,但其对身体形象投资维度的作用却鲜有探讨。本研究以社会比较理论和自我差异理论为框架,假设 PIU 通过 Instagram(IG)上的实际外貌比较和掩盖身体缺陷的需要的串联中介作用,对身体投资和外貌管理行为产生负面影响。性别、年龄和特质外貌比较是控制因素:招募了 323 名参与者(女=70.3%;男=28.92 + 10.96),并在线实施了众所周知的自我报告测量:结构模型产生了良好的拟合指数[χ2/df = 2.36, RMSEA = 0.065 (0.053 - 0.077), CFI = 0.962, SRMR = 0.038],变量分别占身体投资和外表管理行为变异的79%和32%。PIU与身体投资直接或间接相关,而只通过Ig上的外表比较影响外表管理行为。测试的替代模型的拟合度低于假设模型,前者的拟合度明显低于假设模型:本研究为更好地理解 PIU 与身体形象投资维度之间联系的心理机制迈出了一步。
{"title":"The Link Between Problematic Instagram Use and Body-Image Investment Dimensions: The Mediating Role of Social Comparison on Instagram and the Need to Conceal Body Flaws.","authors":"Silvia Casale, Chiara Pettini, Giulia Fioravanti, Massimiliano Padovani, Simon Ghinassi","doi":"10.36131/cnfioritieditore20240105","DOIUrl":"10.36131/cnfioritieditore20240105","url":null,"abstract":"<p><strong>Objective: </strong>The negative effects of Problematic Instagram Use (PIU) on self-evaluations of one's appearance (i.e., body-image satisfaction-dissatisfaction) are well-known, whereas less explored is its role on body-image investment dimensions. By adopting the Social Comparison and the Self-discrepancies theories as the framework, the present study hypothesized that PIU negatively affects body investment and appearance management behaviours through the serial mediating role of actual appearance comparison on Instagram (IG) and the need to conceal body flaws. Gender, age and trait appearance comparison were controlled for.</p><p><strong>Method: </strong>A convenience sample of 323 participants (F = 70.3%; M= 28.92 + 10.96) was recruited, and well-known self-report measures were administered online.</p><p><strong>Results: </strong>The structural model produced good fit indices [χ2/df = 2.36, RMSEA = 0.065 (0.053 - 0.077), CFI = 0.962, SRMR = 0.038], and the variables accounted for 79% and 32% of the variance in body investment and appearance management behaviours, respectively. PIU was associated with body investment both directly and indirectly, whereas it affected appearance management behaviours only via appearance comparison on Ig. The tested alternative model has a poorer fit than the hypothesized model, and the former fitted significantly worse than the proposed one.</p><p><strong>Conclusions: </strong>The present study represents a step toward a better understanding of the psychological mechanisms underlying the link between PIU and body image investment dimensions.</p>","PeriodicalId":46700,"journal":{"name":"Clinical Neuropsychiatry","volume":"21 1","pages":"79-87"},"PeriodicalIF":6.1,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10979791/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140337158","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Treating Guilt-Inducing Self-Talk in Ocd with Dramatized Socratic Dialogue: A Step by Step Intervention. 用戏剧化苏格拉底对话治疗老年痴呆症患者的内疚自言自语:逐步干预。
IF 6.1 Q3 CLINICAL NEUROLOGY Pub Date : 2024-02-01 DOI: 10.36131/cnfioritieditore2023060104
Angelo Maria Saliani, Claudia Perdighe, Vittoria Zaccari, Olga Ines Luppino, Alessandra Mancini, Katia Tenore, Francesco Mancini

Objective: Fear of moral guilt and conseque:nt increased attention to personal actions and intentions are the main ingredients of the self-criticism in patients suffering from obsessive-compulsive disorder (OCD). This pathogenic attitude takes shape in a typical guilt-inducing self-talk.The purpose of this work is to describe in detail a novel cognitive therapeutic procedure for OCD called "Dramatized Socratic Dialogue" (DSD).

Method: DSD is a theory-oriented intervention that combine elements of Socratic dialogue, chairwork, and cognitive acceptance strategies derived from Mancini's model, which posits that obsessive-compulsive (OC) symptoms stem from a fear of deontological guilt.

Results: DSD appears to have many strengths, being a theory-oriented treatment and focusing, as a therapeutic target, on the cognitive structures that determine pathogenic processes and OC symptoms. Furthermore, it is a short, flexible and tailor-made intervention.

Conclusions: Detailed description of the intervention could foster future research perspectives and thus be used in evidence-based effectiveness studies to establish whether DSD reduces OC symptoms and to investigate its mechanism of action.

目的:对道德负罪感的恐惧和对个人行为和意图的日益关注是强迫症(OCD)患者自我批判的主要因素。这种致病态度表现为典型的内疚型自言自语。本文旨在详细介绍一种治疗强迫症的新型认知疗法,即 "戏剧化苏格拉底对话"(DSD):DSD是一种以理论为导向的干预方法,它结合了苏格拉底式对话、椅子工作和源自曼奇尼模型的认知接受策略等元素,曼奇尼模型认为强迫症(OC)症状源于对责任感的恐惧:DSD 似乎有很多优点,它是一种以理论为导向的治疗方法,治疗目标集中在决定致病过程和 OC 症状的认知结构上。此外,它还是一种短期、灵活和量身定制的干预方法:对干预措施的详细描述可以促进未来的研究视角,从而用于循证有效性研究,以确定DSD是否能减轻OC症状并研究其作用机制。
{"title":"Treating Guilt-Inducing Self-Talk in Ocd with Dramatized Socratic Dialogue: A Step by Step Intervention.","authors":"Angelo Maria Saliani, Claudia Perdighe, Vittoria Zaccari, Olga Ines Luppino, Alessandra Mancini, Katia Tenore, Francesco Mancini","doi":"10.36131/cnfioritieditore2023060104","DOIUrl":"10.36131/cnfioritieditore2023060104","url":null,"abstract":"<p><strong>Objective: </strong>Fear of moral guilt and conseque:nt increased attention to personal actions and intentions are the main ingredients of the self-criticism in patients suffering from obsessive-compulsive disorder (OCD). This pathogenic attitude takes shape in a typical guilt-inducing self-talk.The purpose of this work is to describe in detail a novel cognitive therapeutic procedure for OCD called \"Dramatized Socratic Dialogue\" (DSD).</p><p><strong>Method: </strong>DSD is a theory-oriented intervention that combine elements of Socratic dialogue, chairwork, and cognitive acceptance strategies derived from Mancini's model, which posits that obsessive-compulsive (OC) symptoms stem from a fear of deontological guilt.</p><p><strong>Results: </strong>DSD appears to have many strengths, being a theory-oriented treatment and focusing, as a therapeutic target, on the cognitive structures that determine pathogenic processes and OC symptoms. Furthermore, it is a short, flexible and tailor-made intervention.</p><p><strong>Conclusions: </strong>Detailed description of the intervention could foster future research perspectives and thus be used in evidence-based effectiveness studies to establish whether DSD reduces OC symptoms and to investigate its mechanism of action.</p>","PeriodicalId":46700,"journal":{"name":"Clinical Neuropsychiatry","volume":"21 1","pages":"63-78"},"PeriodicalIF":6.1,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10979789/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140337159","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effectiveness of Ketamine for the Treatment of Post-Traumatic Stress Disorder - A Systematic Review and Meta-Analysis. 氯胺酮治疗创伤后应激障碍的有效性--系统回顾与元分析》。
IF 6.1 Q3 CLINICAL NEUROLOGY Pub Date : 2024-02-01 DOI: 10.36131/cnfioritieditore20240102
Thales Marcon Almeida, Ursula Raianny Lacerda da Silva, Jeully Pereira Pires, Isaac Neri Borges, Clara Rosa Muniz Martins, Quirino Cordeiro, Ricardo R Uchida

Objective: Post-traumatic stress disorder (PTSD) is an enduring condition characterized by a chronic course and impairments across several areas. Despite its significance, treatment options remain limited, and remission rates are often low. Ketamine has demonstrated antidepressant properties and appears to be a promising agent in the management of PTSD.

Method: A systematic review was conducted in PubMed/MEDLINE, Cochrane Library, Clinicaltrials.gov, Lilacs, Scopus, and Embase, covering studies published between 2012 and December 2022 to assess the effectiveness of ketamine in the treatment of PTSD. Ten studies, consisting of five RCTs, two crossover trials, and three non-randomized trials, were included in the meta-analysis.

Results: Ketamine demonstrated significant improvements in PCL-5 scores, both 24 hours after the initial infusion and at the endpoint of the treatment course, which varied between 1 to 4 weeks in each study. Notably, the significance of these differences was assessed using the Two Sample T-test with pooled variance and the Two Sample Welch's T-test, revealing a statistically significant effect for ketamine solely at the endpoint of the treatment course (standardized effect size= 0.25; test power 0.9916; 95% CI = 0.57 to 17.02, p=0.0363). It is important to note that high heterogeneity was observed across all analyses.

Conclusions: Our findings suggest that ketamine holds promise as an effective treatment option for PTSD. However, further trials are imperative to establish robust data for this intervention.

目的:创伤后应激障碍(PTSD创伤后应激障碍(PTSD)是一种持久性疾病,其特点是病程慢性,并在多个方面存在障碍。尽管创伤后应激障碍非常重要,但治疗方案仍然有限,而且缓解率往往很低。氯胺酮具有抗抑郁特性,似乎是治疗创伤后应激障碍的一种有前途的药物:方法:我们在PubMed/MEDLINE、Cochrane图书馆、Clinicaltrials.gov、Lilacs、Scopus和Embase上进行了系统综述,涵盖了2012年至2022年12月期间发表的研究,以评估氯胺酮治疗创伤后应激障碍的有效性。荟萃分析纳入了10项研究,包括5项RCT、2项交叉试验和3项非随机试验:结果:氯胺酮显著改善了PCL-5评分,无论是首次输注后24小时,还是疗程结束时(每项研究的疗程均在1至4周之间)。值得注意的是,这些差异的显著性是用集合方差两样本 T 检验和两样本韦尔奇 T 检验来评估的,结果显示氯胺酮仅在疗程结束时有显著的统计学效应(标准化效应大小= 0.25;检验功率 0.9916;95% CI = 0.57 至 17.02,P=0.0363)。值得注意的是,在所有分析中都观察到了高度异质性:我们的研究结果表明,氯胺酮有望成为创伤后应激障碍的有效治疗方案。结论:我们的研究结果表明,氯胺酮有望成为治疗创伤后应激障碍的有效方法。
{"title":"Effectiveness of Ketamine for the Treatment of Post-Traumatic Stress Disorder - A Systematic Review and Meta-Analysis.","authors":"Thales Marcon Almeida, Ursula Raianny Lacerda da Silva, Jeully Pereira Pires, Isaac Neri Borges, Clara Rosa Muniz Martins, Quirino Cordeiro, Ricardo R Uchida","doi":"10.36131/cnfioritieditore20240102","DOIUrl":"10.36131/cnfioritieditore20240102","url":null,"abstract":"<p><strong>Objective: </strong>Post-traumatic stress disorder (PTSD) is an enduring condition characterized by a chronic course and impairments across several areas. Despite its significance, treatment options remain limited, and remission rates are often low. Ketamine has demonstrated antidepressant properties and appears to be a promising agent in the management of PTSD.</p><p><strong>Method: </strong>A systematic review was conducted in PubMed/MEDLINE, Cochrane Library, Clinicaltrials.gov, Lilacs, Scopus, and Embase, covering studies published between 2012 and December 2022 to assess the effectiveness of ketamine in the treatment of PTSD. Ten studies, consisting of five RCTs, two crossover trials, and three non-randomized trials, were included in the meta-analysis.</p><p><strong>Results: </strong>Ketamine demonstrated significant improvements in PCL-5 scores, both 24 hours after the initial infusion and at the endpoint of the treatment course, which varied between 1 to 4 weeks in each study. Notably, the significance of these differences was assessed using the Two Sample T-test with pooled variance and the Two Sample Welch's T-test, revealing a statistically significant effect for ketamine solely at the endpoint of the treatment course (standardized effect size= 0.25; test power 0.9916; 95% CI = 0.57 to 17.02, p=0.0363). It is important to note that high heterogeneity was observed across all analyses.</p><p><strong>Conclusions: </strong>Our findings suggest that ketamine holds promise as an effective treatment option for PTSD. However, further trials are imperative to establish robust data for this intervention.</p>","PeriodicalId":46700,"journal":{"name":"Clinical Neuropsychiatry","volume":"21 1","pages":"22-31"},"PeriodicalIF":6.1,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10979792/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140337183","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Inflammatory Biomarkers, Cognitive Functioning, and Brain Imaging Abnormalities in Bipolar Disorder: A Systematic Review. 双相情感障碍的炎症生物标志物、认知功能和脑成像异常:系统回顾
IF 6.1 Q3 CLINICAL NEUROLOGY Pub Date : 2024-02-01 DOI: 10.36131/cnfioritieditore20240103
Altamura Mario, Leccisotti Ivana, Mollica Anita, Maddalena Silvio, Altamura Claudia, Moretti Mariaclaudia, Bellomo Antonello

Objective: Recent studies have pointed to neuroinflammation and neurotrophic factors as crucial mediators in the pathophysiology origins of mood disorders. The aim of this review is to assess the potential association between cognitive impairment, brain imaging abnormalities, and inflammatory biomarkers in patients affected by bipolar disorder (BD).

Method: Following PRISMA (Preferred Reporting Items for Systematic reviews and Meta-analyses) guidelines, we systematically searched PubMed, Google Scholar, Scopus, and Web of Science databases, with no year restriction, up until August 2023, for human studies that examined the relationship between inflammatory markers and cognitive impairment in BD patients. Studies based on neuroimaging, such as MRI, DTI, and fMRI, were also included, along with those examining the moderating role of specific inflammatory markers in the alteration of the brain.

Results: 59 human clinical studies satisfied the criteria for consideration. Most of the studies reviewed concur that inflammatory state, measured by peripheral blood levels of CRP and cytokines, constitutes an important contributor to cognitive impairment observed in patients with BD. Robust evidence indicates an association between cognitive impairment and CRP, IL-1RA, IL-6, and TNF-α with its receptors, whereas there is no convincing evidence for the involvement of other neuroinflammatory biomarkers. Neuroimaging studies suggest that brain structural/functional abnormalities seen in BD could also be linked to a neuroinflammatory condition.

Conclusions: Current data provide evidence of a link between cognitive impairments observed in BD patients and mechanisms of neuroinflammation. Emerging evidence indicates that systemic inflammation might also play an important role in the deterioration of brain structures critical to cognitive functions in patients with BD. The convergence of findings across these studies strengthens our understanding of the complex neurobiological underpinnings of these disorders. Identification of BD specific inflammatory markers may be of assistance for future early therapeutic interventions.

目的:最近的研究指出,神经炎症和神经营养因子是情绪障碍病理生理学起源的关键介质。本综述旨在评估双相情感障碍(BD)患者的认知障碍、脑成像异常和炎症生物标志物之间的潜在关联:根据PRISMA(系统综述和荟萃分析的首选报告项目)指南,我们系统地检索了PubMed、Google Scholar、Scopus和Web of Science数据库(无年份限制,截止到2023年8月)中研究双相情感障碍患者的炎症标志物与认知障碍之间关系的人类研究。此外,还包括基于神经影像学(如 MRI、DTI 和 fMRI)的研究,以及研究特定炎症标志物在大脑变化中的调节作用的研究:59 项人类临床研究符合审议标准。所审查的大多数研究一致认为,以外周血 CRP 和细胞因子水平衡量的炎症状态是导致 BD 患者认知障碍的一个重要因素。大量证据表明,认知障碍与 CRP、IL-1RA、IL-6 和 TNF-α 及其受体有关,但没有令人信服的证据表明其他神经炎症生物标志物也参与其中。神经影像学研究表明,BD 的大脑结构/功能异常也可能与神经炎症有关:目前的数据证明,在 BD 患者中观察到的认知障碍与神经炎症机制之间存在联系。新出现的证据表明,全身性炎症也可能在对 BD 患者认知功能至关重要的大脑结构退化过程中扮演重要角色。这些研究结果的汇集加强了我们对这些疾病复杂的神经生物学基础的了解。鉴定 BD 特异性炎症标志物可能有助于未来的早期治疗干预。
{"title":"Inflammatory Biomarkers, Cognitive Functioning, and Brain Imaging Abnormalities in Bipolar Disorder: A Systematic Review.","authors":"Altamura Mario, Leccisotti Ivana, Mollica Anita, Maddalena Silvio, Altamura Claudia, Moretti Mariaclaudia, Bellomo Antonello","doi":"10.36131/cnfioritieditore20240103","DOIUrl":"10.36131/cnfioritieditore20240103","url":null,"abstract":"<p><strong>Objective: </strong>Recent studies have pointed to neuroinflammation and neurotrophic factors as crucial mediators in the pathophysiology origins of mood disorders. The aim of this review is to assess the potential association between cognitive impairment, brain imaging abnormalities, and inflammatory biomarkers in patients affected by bipolar disorder (BD).</p><p><strong>Method: </strong>Following PRISMA (Preferred Reporting Items for Systematic reviews and Meta-analyses) guidelines, we systematically searched PubMed, Google Scholar, Scopus, and Web of Science databases, with no year restriction, up until August 2023, for human studies that examined the relationship between inflammatory markers and cognitive impairment in BD patients. Studies based on neuroimaging, such as MRI, DTI, and fMRI, were also included, along with those examining the moderating role of specific inflammatory markers in the alteration of the brain.</p><p><strong>Results: </strong>59 human clinical studies satisfied the criteria for consideration. Most of the studies reviewed concur that inflammatory state, measured by peripheral blood levels of CRP and cytokines, constitutes an important contributor to cognitive impairment observed in patients with BD. Robust evidence indicates an association between cognitive impairment and CRP, IL-1RA, IL-6, and TNF-α with its receptors, whereas there is no convincing evidence for the involvement of other neuroinflammatory biomarkers. Neuroimaging studies suggest that brain structural/functional abnormalities seen in BD could also be linked to a neuroinflammatory condition.</p><p><strong>Conclusions: </strong>Current data provide evidence of a link between cognitive impairments observed in BD patients and mechanisms of neuroinflammation. Emerging evidence indicates that systemic inflammation might also play an important role in the deterioration of brain structures critical to cognitive functions in patients with BD. The convergence of findings across these studies strengthens our understanding of the complex neurobiological underpinnings of these disorders. Identification of BD specific inflammatory markers may be of assistance for future early therapeutic interventions.</p>","PeriodicalId":46700,"journal":{"name":"Clinical Neuropsychiatry","volume":"21 1","pages":"32-62"},"PeriodicalIF":6.1,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10979794/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140337154","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
No Impact of Tdcs on Stress-Induced State Rumination and no Influence of Executive Control and Trait Rumination: A Double-Blind Sham-Controlled Within-Subjects Study. Tdcs对压力诱发的状态反刍没有影响,执行控制和特质反刍也没有影响:双盲假对照受试者内研究。
IF 6.1 Q3 CLINICAL NEUROLOGY Pub Date : 2024-02-01 DOI: 10.36131/cnfioritieditore20240107
Yorgo Hoebeke, Marie-Anne Vanderhasselt, Marion Carême, Pierre Maurage, Alexandre Heeren

Objective: Rumination is conceptualized as a critical transdiagnostic vulnerability and maintenance factor for affective dysregulation and related emotional disorders. Recent research has pointed to transcranial direct current stimulation (tDCS) as a novel therapeutic tool for alleviating rumination, especially stress-induced rumination. However, the mechanisms of action underlying this effect remain unclear, particularly regarding the potential moderating role of executive control and trait-like rumination. Therefore, in this study, we investigated the impact of anodal tDCS on stress-induced rumination and the potential moderating influence of executive control and trait-like rumination on this efect.

Method: Forty participants from the general community (i.e., unselected sample) took part in a double-blind within-subjects design study wherein we compared anodal stimulation over the left dorsolateral prefrontal cortex(dlPFC) with a sham-stimulation procedure. Participants completed an N-back task, reflecting executive control, during tDCS stimulation, followed by a stress-induction protocol wherein we assessed stress-induced state rumination.

Results: We found no significant effect of tDCS on stress-induced state rumination and no modulation by executive control or trait rumination. Post-hoc Bayesian analyses corroborated these results and even supported the hypothesis that anodal tDCS does not impact stress-induced rumination.

Conclusions: From a clinical perspective, our results are at odds with the current outlook that tDCS is a viable tool for reducing rumination, particularly stress-induced rumination. However, we firmly believe that the results of null-finding studies, such as those from this study, are particularly valuable for future iterations and meta-researchon tDCS as a potential tool for targeting transdiagnostic processes, such as rumination. We also addressed methodological limitations and directions for future research in this area.

目的:反刍被认为是情感失调和相关情绪障碍的一个重要的跨诊断易感性和维持因素。最近的研究表明,经颅直流电刺激(tDCS)是一种新型的治疗工具,可减轻反刍,尤其是压力引起的反刍。然而,这种效果的作用机制仍不清楚,特别是关于执行控制和特质样反刍的潜在调节作用。因此,在本研究中,我们调查了阳极tDCS对压力诱发的反刍的影响,以及执行控制和特质类反刍对这种影响的潜在调节作用:40名来自普通社区的参与者(即未选样本)参加了一项双盲受试内设计研究,我们在研究中比较了对左侧背外侧前额叶皮层(dlPFC)的阳极刺激和假刺激过程。受试者在tDCS刺激过程中完成了一项反映执行控制能力的N-back任务,随后完成了一项压力诱导方案,我们在该方案中评估了压力诱导的状态反刍:结果:我们发现 tDCS 对压力诱发的状态反刍没有明显影响,也不受执行控制或特质反刍的调节。事后贝叶斯分析证实了这些结果,甚至支持了阳极tDCS不会影响压力诱发的反刍的假设:从临床角度来看,我们的研究结果与目前认为 tDCS 是减少反刍(尤其是应激诱发的反刍)的可行工具的观点不一致。但是,我们坚信,像本研究这样的无效发现研究结果,对于未来将 tDCS 作为针对反刍等跨诊断过程的潜在工具进行迭代和元研究具有特别重要的价值。我们还探讨了该领域的方法论局限性和未来研究方向。
{"title":"No Impact of Tdcs on Stress-Induced State Rumination and no Influence of Executive Control and Trait Rumination: A Double-Blind Sham-Controlled Within-Subjects Study.","authors":"Yorgo Hoebeke, Marie-Anne Vanderhasselt, Marion Carême, Pierre Maurage, Alexandre Heeren","doi":"10.36131/cnfioritieditore20240107","DOIUrl":"10.36131/cnfioritieditore20240107","url":null,"abstract":"<p><strong>Objective: </strong>Rumination is conceptualized as a critical transdiagnostic vulnerability and maintenance factor for affective dysregulation and related emotional disorders. Recent research has pointed to transcranial direct current stimulation (tDCS) as a novel therapeutic tool for alleviating rumination, especially stress-induced rumination. However, the mechanisms of action underlying this effect remain unclear, particularly regarding the potential moderating role of executive control and trait-like rumination. Therefore, in this study, we investigated the impact of anodal tDCS on stress-induced rumination and the potential moderating influence of executive control and trait-like rumination on this efect.</p><p><strong>Method: </strong>Forty participants from the general community (i.e., unselected sample) took part in a double-blind within-subjects design study wherein we compared anodal stimulation over the left dorsolateral prefrontal cortex(dlPFC) with a sham-stimulation procedure. Participants completed an N-back task, reflecting executive control, during tDCS stimulation, followed by a stress-induction protocol wherein we assessed stress-induced state rumination.</p><p><strong>Results: </strong>We found no significant effect of tDCS on stress-induced state rumination and no modulation by executive control or trait rumination. Post-hoc Bayesian analyses corroborated these results and even supported the hypothesis that anodal tDCS does not impact stress-induced rumination.</p><p><strong>Conclusions: </strong>From a clinical perspective, our results are at odds with the current outlook that tDCS is a viable tool for reducing rumination, particularly stress-induced rumination. However, we firmly believe that the results of null-finding studies, such as those from this study, are particularly valuable for future iterations and meta-researchon tDCS as a potential tool for targeting transdiagnostic processes, such as rumination. We also addressed methodological limitations and directions for future research in this area.</p>","PeriodicalId":46700,"journal":{"name":"Clinical Neuropsychiatry","volume":"21 1","pages":"99-109"},"PeriodicalIF":6.1,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10979793/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140337156","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Silent Infections are not So Silent: The Emerging Role of Combined Infections, Inflammation, and Vitamin Levels in OCD. 沉默的感染并不那么沉默:综合感染、炎症和维生素水平在强迫症中的新作用。
IF 6.1 Q3 CLINICAL NEUROLOGY Pub Date : 2024-02-01 DOI: 10.36131/cnfioritieditore20240101
Donatella Marazziti, Lucia Massa, Manuel Glauco Carbone, Stefania Palermo, Alessandro Arone, Giorgia D'Angelo, Nicola Schulz Bizzozzero Crivelli, Riccardo Gurrieri, Paola Perrone, Laura Palagini, Liliana Dell'Osso

Objective: Recent evidence highlights that different agents may trigger immune-mediated processes involved in the pathophysiology of different neuropsychiatric conditions. Given the limited information on obsessive-compulsive disorder (OCD), the present study aimed at assessing current/past infections and plasma levels of vitamin D, vitamin B12, folic acid, homocysteine and common peripheral inflammatory markers in a group of OCD outpatients.

Method: The sample included 217 adult outpatients with an OCD diagnosis according to the DSM-5 criteria. The Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) was used to assess the clinical phenotype and symptom severity. Laboratory blood tests measured levels of vitamin D, vitamin B12, folic acid, homocysteine, erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), blood count and antibodies titers for cytomegalovirus (CMV), Epstein Barr virus (EBV), Toxoplasma gondii and antistreptolysin titer.

Results: Sixty-one patients had a previous EBV infection, 46 were seropositive for CMV IgG, 24 showed positive antistreptolysin titer, 14 were seropositive for Toxoplasma gondii IgG, and four for CMV IgM. More than a half of patients showed vitamin D insufficiency. Compared to seronegative patients, patients with a past EBV infection displayed significantly higher scores on the Y-BOCS total score and compulsion subscale, and other symptoms. Vitamin D was negatively correlated with both the Y-BOCS total score and the subscales scores. Folic acid was negatively correlated with the Y-BOCS total and obsessions subscale score.

Conclusions: The findings of our study show an association between Epstein-Barr infection and hypovitaminosis D and the overall severity and specific symptom patterns of OCD. The laboratory measures used in this study are useful, cheap and easy parameters that should be routinely assessed in patients with OCD. Further studies are needed to clarify their role in OCD pathophysiology and outcomes, as well as the potential therapeutic impact of vitamins and antibiotics/immunomodulatory agents in OCD and other psychiatric conditions.

目的:最近的证据表明,不同的药物可能会引发免疫介导过程,从而参与不同神经精神疾病的病理生理学。鉴于有关强迫症(OCD)的信息有限,本研究旨在评估一组强迫症门诊患者当前/既往感染情况以及血浆中维生素 D、维生素 B12、叶酸、同型半胱氨酸和常见外周炎症标志物的水平:样本包括217名根据DSM-5标准诊断为强迫症的成年门诊患者。耶鲁-布朗强迫症量表(Y-BOCS)用于评估临床表型和症状严重程度。血液化验检测了维生素 D、维生素 B12、叶酸、同型半胱氨酸、红细胞沉降率 (ESR)、C 反应蛋白 (CRP)、血细胞计数以及巨细胞病毒 (CMV)、爱泼斯坦巴氏病毒 (EBV)、弓形虫抗体滴度和抗链霉素滴度:61 名患者曾感染过 EBV,46 名患者的 CMV IgG 血清阳性,24 名患者的抗链霉素滴度阳性,14 名患者的弓形虫 IgG 血清阳性,4 名患者的 CMV IgM 血清阳性。半数以上的患者维生素 D 不足。与血清阴性患者相比,既往感染过 EBV 的患者在 Y-BOCS 总分、强迫分量表和其他症状上的得分明显更高。维生素 D 与 Y-BOCS 总分和分量表得分均呈负相关。叶酸与 Y-BOCS 总分和强迫症分量表得分呈负相关:我们的研究结果表明,Epstein-Barr 感染和维生素 D 不足与强迫症的总体严重程度和特定症状模式之间存在关联。本研究中使用的实验室测量方法是有用、廉价和简便的参数,应在强迫症患者中进行常规评估。还需要进一步的研究来明确它们在强迫症病理生理学和预后中的作用,以及维生素和抗生素/免疫调节剂对强迫症和其他精神疾病的潜在治疗作用。
{"title":"Silent Infections are not So Silent: The Emerging Role of Combined Infections, Inflammation, and Vitamin Levels in OCD.","authors":"Donatella Marazziti, Lucia Massa, Manuel Glauco Carbone, Stefania Palermo, Alessandro Arone, Giorgia D'Angelo, Nicola Schulz Bizzozzero Crivelli, Riccardo Gurrieri, Paola Perrone, Laura Palagini, Liliana Dell'Osso","doi":"10.36131/cnfioritieditore20240101","DOIUrl":"10.36131/cnfioritieditore20240101","url":null,"abstract":"<p><strong>Objective: </strong>Recent evidence highlights that different agents may trigger immune-mediated processes involved in the pathophysiology of different neuropsychiatric conditions. Given the limited information on obsessive-compulsive disorder (OCD), the present study aimed at assessing current/past infections and plasma levels of vitamin D, vitamin B12, folic acid, homocysteine and common peripheral inflammatory markers in a group of OCD outpatients.</p><p><strong>Method: </strong>The sample included 217 adult outpatients with an OCD diagnosis according to the DSM-5 criteria. The Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) was used to assess the clinical phenotype and symptom severity. Laboratory blood tests measured levels of vitamin D, vitamin B12, folic acid, homocysteine, erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), blood count and antibodies titers for cytomegalovirus (CMV), Epstein Barr virus (EBV), Toxoplasma gondii and antistreptolysin titer.</p><p><strong>Results: </strong>Sixty-one patients had a previous EBV infection, 46 were seropositive for CMV IgG, 24 showed positive antistreptolysin titer, 14 were seropositive for Toxoplasma gondii IgG, and four for CMV IgM. More than a half of patients showed vitamin D insufficiency. Compared to seronegative patients, patients with a past EBV infection displayed significantly higher scores on the Y-BOCS total score and compulsion subscale, and other symptoms. Vitamin D was negatively correlated with both the Y-BOCS total score and the subscales scores. Folic acid was negatively correlated with the Y-BOCS total and obsessions subscale score.</p><p><strong>Conclusions: </strong>The findings of our study show an association between Epstein-Barr infection and hypovitaminosis D and the overall severity and specific symptom patterns of OCD. The laboratory measures used in this study are useful, cheap and easy parameters that should be routinely assessed in patients with OCD. Further studies are needed to clarify their role in OCD pathophysiology and outcomes, as well as the potential therapeutic impact of vitamins and antibiotics/immunomodulatory agents in OCD and other psychiatric conditions.</p>","PeriodicalId":46700,"journal":{"name":"Clinical Neuropsychiatry","volume":"21 1","pages":"7-21"},"PeriodicalIF":6.1,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10979795/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140337157","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Clinical Neuropsychiatry
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1